Atlas Trials

Coronary Artery Stenosis

100 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Coronary Artery Stenosis

RecordFirmDate
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (NCT04985773)Infraredx2021-12-17
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II (NCT04893291)Fondazione Ricerca e Innovazione Cardiovascolare ETS2021-11-16
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis (NCT05133843)Helios Health Institute GmbH2021-09-29
Relation Between AI-QCA and Cardiac PET (NCT06397820)Chonnam National University Hospital2021-09-01
Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis (NCT05320185)Shenzhen Raysight Intelligent Medical Technology Co., Ltd.2021-07-28
A Study to Evaluate Direct Wire Pacing (DWP) for Measuring Fractional Flow Reserve (FFR) (NCT04970082)Centre Recherche Cardio Vasculaire Alpes2021-06-17
ANGiographic Evaluation of Left Main Coronary Artery INtErvention (NCT04604197)Fundación EPIC2021-04-16
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries (NCT04192747)Elixir Medical Corporation2020-12-16
Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis (NCT04666584)Odense University Hospital2020-12-14
Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve (NCT06844942)Medical University of Warsaw2020-09-20
FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing (NCT04401657)Asan Medical Center2020-05-08
Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE) (NCT04126148)McGill University Health Centre/Research Institute of the McGill University Health Centre2019-07-04
Optimal Predilatation Technique for BVS Implantation (NCT02946320)Cardiology Center Agel2016-11-01
Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III) (NCT02716220)Biotronik AG2016-03-01
DESolve® X-Pand Global Post Market Registry (NCT02453035)Elixir Medical Corporation2015-05-13
Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE (NCT02681016)Meshalkin Research Institute of Pathology of Circulation2015-03-01
Absorb IV Randomized Controlled Trial (NCT02173379)Abbott Medical Devices2014-07-01
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions (NCT02229864)Abbott Medical Devices2014-05-01
Angiography Study of BioNIR Drug Eluting Stent System (NIREUS) (NCT01995500)Medinol Ltd.2014-03-19
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis (NCT01995487)Medinol Ltd.2014-01-01
First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (NCT01960504)Biotronik AG2013-10-01
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (NCT01923740)Abbott Medical Devices2013-07-01
Cordimax China Post Market Surveillance (NCT03185221)Shandong Branden Med.Device Co.,Ltd2013-06-20
ReZolve2 Clinical Investigation (NCT01845311)REVA Medical, Inc.2013-04-01
ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. (NCT01759290)Abbott Medical Devices2013-01-01
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention (NCT06281041)Samsung Medical Center2013-01-01
ABSORB III Randomized Controlled Trial (RCT) (NCT01751906)Abbott Medical Devices2012-12-01
XIENCE PRIME Japan Post-Marketing Surveillance (PMS) (NCT01721096)Abbott Medical Devices2012-10-01
A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis (NCT01513070)Guang'anmen Hospital of China Academy of Chinese Medical Sciences2012-04-01
HanYang University Medical Center (HYUMC) Registry (NCT05935397)Hanyang University Seoul Hospital2012-01-01
Safety Study of a Bioresorbable Coronary Stent (NCT01262703)REVA Medical, Inc.2011-12-01
The Real-world Firebird 2 Versus Cypher Sirolimus-eluting Stent in Treating Patients With Coronary Artery Disease (NCT01328730)Shanghai Jiao Tong University School of Medicine2011-04-01
T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO) (NCT02708329)Meshalkin Research Institute of Pathology of Circulation2011-01-01
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (NCT01249027)Abbott Medical Devices2010-11-01
Kidney Damage in Patients With Moderate Fall in eGFR (NCT01136876)Bracco Diagnostics, Inc2010-11-01
Kidney Damage In Patients With Severe Fall In eGFR (NCT01136915)Bracco Diagnostics, Inc2010-11-01
Stress-MRI Assessment After Right Coronary Artery CTO Recanalization (NCT02769650)Meshalkin Research Institute of Pathology of Circulation2010-10-01
EXCEL Clinical Trial (Universal Registry) (NCT01205789)Abbott Medical Devices2010-10-01
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (NCT01342822)European Cardiovascular Research Center2010-10-01
EXCEL Clinical Trial (NCT01205776)Abbott Medical Devices2010-09-29
A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions (NCT01186198)Abbott Medical Devices2010-08-12
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) (NCT01178268)Abbott Medical Devices2010-08-01
Main Branch Versus Side Branch Ostial Lesion (NCT01335659)Seoul National University Hospital2010-06-01
Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis (NCT01401140)Centre Hospitalier Universitaire de Saint Etienne2010-06-01
A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (NCT01115933)Abbott Medical Devices2010-04-01
Fractional Flow Reserve (FFR) Versus Intravascular Ultrasound (IVUS) in Intermediate Coronary Artery Disease (NCT01175863)Ajou University School of Medicine2010-02-01
Chronic Total Occlusion Registry (NCT04041921)Seung-Jung Park2010-01-01
ABSORB EXTEND Clinical Investigation (NCT01023789)Abbott Medical Devices2010-01-01
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (NCT01106534)Abbott Medical Devices2009-08-01
De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions (NCT00934752)C. R. Bard2009-07-01
COmplex BifuRcation Lesions: A Comparison Between the AXXESS Device and Culotte Stenting: An Optical Coherence Tomography (OCT) Study (NCT00895791)Universitaire Ziekenhuizen KU Leuven2009-06-01
SPIRIT PRIME Clinical Trial (NCT00916370)Abbott Medical Devices2009-06-01
Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism (NCT00891670)Gyeongsang National University Hospital2009-05-01
Coronary Artery Stent Evaluation With 320-slice Computed Tomography - The CArS 320 Study (NCT00967876)Charite University, Berlin, Germany2009-04-01
Comparison of Fractional Flow Reserve and Intravascular Ultrasound (NCT01133015)Seoul National University Hospital2009-03-01
Fractional Flow Reserve and Intravascular Ultrasound in Evaluating Intermediate Coronary Lesions (NCT01414361)Seoul National University Hospital2009-03-01
Steroid-induced Reduction of Surgical Stress Study (NCT00807521)Amsterdam UMC, location VUmc2008-12-01
Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses (NCT00817102)Piedmont Healthcare2008-11-01
Multivessel Disease Diagnosed at the Time of PPCI for STEMI: Complete Revascularization Versus Conservative Strategy. (NCT01332591)St. Anne's University Hospital Brno, Czech Republic2008-09-01
XIENCE V: SPIRIT WOMEN Sub-study (NCT01182428)Abbott Medical Devices2008-09-01
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) (NCT01120379)Abbott Medical Devices2008-07-01
320-slice Coronary Computed Tomography (CT) Angiography (NCT00721851)Charite University, Berlin, Germany2008-04-01
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (NCT01310309)Abbott Medical Devices2007-09-01
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (NCT00531011)Abbott Medical Devices2007-09-01
Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis (NCT00612521)Ottawa Heart Institute Research Corporation2007-08-01
XIENCE V: SPIRIT WOMEN (NCT00496938)Abbott Medical Devices2007-07-01
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers (NCT00494559)Korea University Anam Hospital2007-07-01
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth (NCT00349895)OrbusNeich2006-08-01
Computed Tomographic Angiography or Conventional Coronary Angiography in Clinical Decision Making (NCT00566059)University Medical Center Groningen2006-05-01
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) (NCT00180479)Abbott Medical Devices2005-06-01
SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System (NCT00180453)Abbott Medical Devices2003-12-01
Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study) (NCT00375063)Ministry of Science and Higher Education, Poland2001-01-01

Track Coronary Artery Stenosis automatically

Every clearance here is in the API, with alerts when new ones post.